Home › Idiopathic Thrombocytopenic Purpura › Virginia
Idiopathic Thrombocytopenic Purpura clinical trials in Virginia
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Virginia.
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Virginia Oncology Associates, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- Hematology Oncology Associates of Fredericksburg, Fredericksburg
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 17, 2026 · NCT07700238Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Inova Schar Cancer Institute, Fairfax
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07104565A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Virginia Oncology Associates, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.